| Current Status of Endoscopic Resection for Superficial Nonampullary Duodenal Epithelial Tumors |
19 |
| Guidelines for Colonic Diverticular Bleeding and Colonic Diverticulitis: Japan Gastroenterological Association |
17 |
| Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use |
16 |
| Liquid Biopsy for the Management of Patients with Colorectal Cancer |
15 |
| An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila |
14 |
| Lavender Color in Linked Color Imaging Enables Noninvasive Detection of Gastric Intestinal Metaplasia |
14 |
| Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer |
12 |
| Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities |
11 |
| Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet |
10 |
| Taking Warfarin with Heparin Replacement and Direct Oral Anticoagulant Is a Risk Factor for Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer |
9 |
| Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers |
9 |
| Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients |
9 |
| Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment |
9 |
| Improved Visibility of Barrett's Esophagus with Linked Color Imaging: Inter- and Intra-Rater Reliability and Quantitative Analysis |
8 |
| Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors |
8 |
| Current Status and Challenges of Endoscopic Treatments for Duodenal Tumors |
7 |
| Characterization of Helicobacter pylori-Naive Early Gastric Cancers |
6 |
| Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation |
6 |
| The Local Defender and Functional Mediator: Gut Microbiome |
6 |
| The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease |
6 |
| MR Defecography in Assessing Functional Defecation Disorder: Diagnostic Value of the Defecation Phase in Detection of Dyssynergic Defecation and Pelvic Floor Prolapse in Females |
6 |
| The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer |
6 |
| Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis |
6 |
| Significance of the Lysyl Oxidase Members Lysyl Oxidase Like and 4 in Gastric Cancer |
6 |
| Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis |
5 |
| Clinicopathological Features and Magnifying Chromoendoscopic Findings of Non-Ampullary Duodenal Epithelial Tumors |
5 |
| Magnifying Endoscopy with Narrow Band Imaging in Estimating the Invasion Depth of Superficial Esophageal Squamous Cell Carcinomas |
5 |
| Hepatocyte Growth Factor Facilitates Esophageal Mucosal Repair and Inhibits the Submucosal Fibrosis in a Rat Model of Esophageal Ulcer |
5 |
| Clinical Utility of Capsule Endoscopy and Double-Balloon Enteroscopy in the Management of Obscure Gastrointestinal Bleeding |
5 |
| Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction |
5 |
| Recurrence Patterns and Outcomes of Salvage Surgery in Cases of Non-Curative Endoscopic Submucosal Dissection without Additional Radical Surgery for Early Gastric Cancer |
5 |
| Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers |
5 |
| Efficacy of Clutch Cutter for Standardizing Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score-Matched Analysis |
5 |
| Endoscopic Ultrasound Guided Choledocho-Enterostomy by Using Lumen Apposing Metal Stent in Patients with Failed Endoscopic Retrograde Cholangiopancreatography: A Literature Review |
4 |
| Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository |
4 |
| Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study |
4 |
| Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin |
4 |
| The Present Status and Future of Barrett's Esophageal Adenocarcinoma in Japan |
4 |
| Temporal Trends in Helicobacter pylori Eradication Success in a Test-and-Treat Population |
4 |
| Transient Receptor Potential Ankyrin 1 and Substance P Mediate the Development of Gastric Mucosal Lesions in a Water Immersion Restraint Stress Rat Model |
4 |
| Immunophenotypes of Ductal Epithelial Cells in Advanced Pancreatic Ductal Adenocarcinoma |
4 |
| Chronic Kidney Disease Elicits an Intestinal Inflammation Resulting in Intestinal Dysmotility Associated with the Activation of Inducible Nitric Oxide Synthesis in Rat |
3 |
| Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy |
3 |
| Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer |
3 |
| Helicobacter pylori Eradication Therapy Ameliorates Latent Digestive Symptoms in Chronic Atrophic Gastritis |
3 |
| High-Salt Diet Gets Involved in Gastrointestinal Diseases through the Reshaping of Gastroenterological Milieu |
3 |
| Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research |
3 |
| Metabolic Endoscopy: Development and Perspectives |
3 |
| The Predictive Value of the Hydrogen Breath Test in the Diagnosis of Fructose Malabsorption |
3 |
| Usefulness of Mean Corpuscular Volume for Detection of Advanced Colorectal Cancer in Patients Older than 85 Years |
3 |
